Results 11 to 20 of about 30,271 (250)

Safety and efficacy of calcipotriene plus betamethasone dipropionate topical suspension in the treatment of extensive scalp psoriasis in adolescents ages 12 to 17 years. [PDF]

, 2014
The objective of this study was to assess the safety and efficacy of the fixed combination calcipotriene 0.005% plus betamethasone dipropionate 0.064% topical suspension in adolescents with extensive scalp psoriasis.
Eichenfield, Lawrence F, Ganslandt, Cecilia, Kurvits, Merle, Schlessinger, Joel   +3 more
core   +1 more source

Immune System Remodelling by Prenatal Betamethasone: Effects on β-Cells and Type 1 Diabetes

Frontiers in Endocrinology, 2020
Type 1 diabetes (T1D) is a multifactorial disease of unknown aetiology. Studies focusing on environment-related prenatal changes, which might have an influence on the development of T1D, are still missing.
David Perna-Barrull, Anna Gieras, Silvia Rodriguez-Fernandez, Eva Tolosa, Marta Vives-Pi   +4 more
doaj   +1 more source

Real-life effectiveness of once-daily calcipotriol and betamethasone dipropionate gel vs. ointment formulations in psoriasis vulgaris: final analysis of the 52-week PRO-long study [PDF]

, 2015
Background: Topical therapies are the mainstay of treatment for psoriasis vulgaris. The fixed combination of calcipotriol (Cal) 50 mu g/g plus betamethasone 0.5 mg/g (as dipropionate; BD) is a first-line topical treatment and available as a gel or ...
Hol, CW, Lambert, Jo, Vink, J
core   +1 more source

Comparison of efficacy of calcipotriol and betamethasone combination with betamethasone alone in plaque psoriasis

National Journal of Physiology, Pharmacy and Pharmacology, 2017
Background: Topical therapy constitutes the first line of management in mild to moderate psoriasis. Studies comparing the treatment outcome of topical calcipotriol and betamethasone dipropionate combination with betamethasone dipropionate alone in plaque
Harish Sardar Singh, Sarala Narayana, Shivakumar Vijayarangam   +2 more
doaj   +1 more source

Safety and efficacy of fluticasone propionate in the topical treatment of skin diseases [PDF]

, 2004
Fluticasone propionate - the first carbothioate corticosteroid - has been classified as a potent anti-inflammatory drug for dermatological use. It is available as 0.05% cream and 0.005% ointment formulations for the acute and maintenance treatment of ...
Atsuta J, Boner AL, Bridgman A, Callen J, Delescluse J, Dooms-Goossens AE, Dykes PJ, Falcoz C, Fisher DA, Goossens A, Harding SM, Hogger P, James M, Johnson M, Johnson M, Juhlin L, Katz HI, Korting HC, Lebwohl M, Li JT, Liu XQ, Llewellyn-Jones CG, Lucky AW, McKenzie AW, McLean HM, Nurnberger FG, Phillipps GH, Roberts DT, Spencer CM, Tharp MD, Venning VA, Wilkinson SM, Wolkerstorfer A, Young MMR   +33 more
core   +1 more source

Does Antenatal Betamethasone Alter White Matter Brain Development in Growth Restricted Fetal Sheep?

Frontiers in Cellular Neuroscience, 2020
Fetal growth restriction (FGR) is a common complication of pregnancy often associated with neurological impairments. Currently, there is no treatment for FGR, hence it is likely these babies will be delivered prematurely, thus being exposed to antenatal ...
Amy E. Sutherland, Tamara Yawno, Margie Castillo-Melendez, Beth J. Allison, Atul Malhotra, Atul Malhotra, Graeme R. Polglase, Leo J. Cooper, Graham Jenkin, Suzanne L. Miller   +9 more
doaj   +1 more source

Betamethasone versus dexamethasone on the fetal movement index in the women with preterm labor: A cross-sectional study [PDF]

Journal of Shahrekord University of Medical Sciences, 2022
Background and aims: Biophysical evaluation of fetal profile and movements is a useful tool for assessing fetal health, which even has significant effects on neonatal health.
Abdolmajid Taheri, Sheida Shabanian, Mohsen Khosravi, Soleiman Kheiri   +3 more
doaj   +1 more source

Oral dosing for antenatal corticosteroids in the Rhesus macaque. [PDF]

, 2019
Antenatal corticosteroids (ACS) are standard of care for women at risk of preterm delivery, although choice of drug, dose or route have not been systematically evaluated.
Bridges, James P, Clarke, Michael W, Jobe, Alan H, Kannan, Paranthaman S, Kemp, Matthew W, Milad, Mark, Miller, Lisa A, Schmidt, Augusto F   +7 more
core   +2 more sources

Effect of Maternal Body Mass Index on the Efficacy of Antenatal Betamethasone Administration in Neonatal Outcomes [PDF]

Iranian Journal of Neonatology, 2022
Background: Maternal obesity affects the health of infants and pregnancy outcomes. Few studies, to the best of our knowledge, have assessed the relationship between maternal body mass index (BMI) at antenatal corticosteroid therapy (ACS) and the ...
Masoumeh Mirzamoradi, Soraya Saleh Gargari, Parichehr Pooransari, Mahboobeh Shirazi, Maryam Ahmadyan, Zahra Naeiji, Nayereh Rahmati, Taraneh Arbabzadeh, Neda Ahmadyan   +8 more
doaj   +1 more source

Effects of antenatal betamethasone on preterm human and mouse ductus arteriosus: comparison with baboon data. [PDF]

, 2018
BackgroundAlthough studies involving preterm infants ≤34 weeks gestation report a decreased incidence of patent ductus arteriosus after antenatal betamethasone, studies involving younger gestation infants report conflicting results.MethodsWe used preterm
A El-Khuffash, AC Vidaeff, AM Ring, B Schmidt, B Thebaud, C Kahler, Christopher W. Hooper, Donald McCurnin, E Michelakis, E Pagni, EJ Plosa, EL Shelton, Elaine L. Shelton, Erin J. Plosa, F Coceani, F Schena, F Waffarn, Ginger L. Milne, H Liu, H Ozdemir, HW Park, J Reese, JD Stewart, Jeff Reese, JJ Coalson, John T. Benjamin, K Momma, K Toyoshima, LW Doyle, LW Gonzales, M Eronen, M Liebowitz, M Liebowitz, N Waleh, N Waleh, N Waleh, N Wasserstrum, Nahid Waleh, Naoko Brown, Noah J. Ehinger, OM Peltoniemi, PA Crowley, RD Roghair, RI Clyman, RI Clyman, Ronald I. Clyman, S Costa, Stanley Poole, Steven Seidner, W Onland, Y Ichikawa   +50 more
core   +2 more sources